MaxCyte Inc
LSE:MXCT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
MaxCyte Inc
LSE:MXCT
|
US |
|
Mhp Se
F:MPQ
|
UA |
|
Community Trust Bancorp Inc
NASDAQ:CTBI
|
US |
|
Telus Corp
TSX:T
|
CA |
|
Aptargroup Inc
NYSE:ATR
|
US |
|
F
|
FinecoBank Banca Fineco SpA
MIL:FBK
|
IT |
|
Hudson Global Inc
NASDAQ:HSON
|
US |
|
Boyd Group Services Inc
TSX:BYD
|
CA |
|
Construction Partners Inc
NASDAQ:ROAD
|
US |
|
C
|
Chorus Ltd
ASX:CNU
|
NZ |
|
InPlay Oil Corp
TSX:IPO
|
CA |
|
EVRAZ plc
LSE:EVR
|
UK |
|
I
|
Indutrade AB
LSE:0H30
|
SE |
|
Sellas Life Sciences Group Inc
NASDAQ:SLS
|
US |
|
PDD Holdings Inc
NASDAQ:PDD
|
CN |
|
A
|
Astera Labs Inc
NASDAQ:ALAB
|
US |
|
Aytu Biopharma Inc
NASDAQ:AYTU
|
US |
|
Abacus Global Management Inc
NYSE:ABX
|
US |
|
Deutsche Lufthansa AG
LSE:0H4A
|
DE |
|
Berry Global Group Inc
NYSE:BERY
|
US |
|
G
|
Geely Automobile Holdings Ltd
DUS:GRU
|
HK |
|
N
|
Nirlon Ltd
BSE:500307
|
IN |
Multiples-Based Value
The Multiples-Based Value for MaxCyte Inc (MXCT) under the Base Case is hidden GBX. Compared with the current market price of 0.7496 GBX, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.